Comunicación
Nº 013
Comunicación |
|
Frede Silvia, Hliba Ernesto.
|
|
1.- Brown P.,Tsai. T:Seroepidemiology for Human Papova virus. Discovery of virgin populations an some unnusual patterns of antibody prevalence among people of the world. Am. J. Epidemiol 102: 1975 331-335
2.- Chang R. :Role of Papillomaviruses. J. Clini Pathol. 43: 1990 269-276.
3.- Cuzzin P. Meneguzzi G: Stepwise transformation and cooperative interaction involving oncogenes of DNA tumors viruses. Advances in viral oncology 6 . Nueva York Editorial G. Klein 1987
4.- Ostrow E, Sown A.,Manias B et al. :A surrey of human cancer for Human papilloma virus DNA filter hibridization. Cancer 59: 1987 429-434
5.- Inoue T. Oka K.,Young II ,Vousden KH, Kyo S. Jing P. Hakura A. Yutsudo M :Dispensability of p53 degradation for tumorigenicity and decreased serum requirement of human papillomavirus type 16 E6. Mol Carcinog 1998 Mar,21(3):215-222.
6.- Su TH,Wang JC,Tseng HH, Chang CP,Chang TA,Wei HJ, Chang, JG. Analysis of FHIT transcripts in cervical and endometrial cancers. Int J Cancer 1998 Apr 13 ,76(2):216-222
7.- Song S, Gulliver GA,Lambert PFHuman papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through P53 dependent and p53 independent pathways Proc Natl Acad Sci U S A mar 3,95 (5) 2290-2295.
8.-Harris MD,Beckyc,Lancaster W.,Gregoire L,Carey TE,Bradfor CR The HPV 6 E6/E7 transforming genes are expressed in inverted Papilloma Otolaryngol Head Neck Surg 1998 Mar,118 (3pt1):312-318
9.- Talis AL,Huibregtse JM,Howley PM: The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV) oisutuve abd HPV-negative cells. J Biol Chem 1998 Mar 13 (273-811) :6439-6445.
10.- Unger ER,Vernon SD,Nisenbaum R,Thomsw Spnne,Miller DL,Lee DR, et all. Human papillomavirus and disease status following therapy cervical cancer
11.- Lizano M,Garcia Carranca A. Molecular variants of human papillomaviruses types 16,18 and 45 in tumors of the uterine cervix in M{exico. Gac. Med. Mex. 1997,133 Supple 1: 43-48
12.-Cooper CS,Upweyer SN, Winokur PL Identification de aminoacids in the human Papillomavirus 11 E2 protein critical fot the transactivation of replication function. Virology 1998 Feb. 15, 241(2) 312-322
13.- Hiekinen S, Syrjanem K, Syrjanen S. Br. J Cancer 1998 Mar,77 (5) 766-775
13.- Watrs DH, Koutsky LA, Holmes KK, Goldman D, Duypers J, et all Low risk of perinatal transmission of human papillomavirus Results form a prospective cohort study. Am J Obstet Gynecol 1998 Feb 178(2) 365-375.
14.- Moscicki AB, Shiboski S, Broerin J. Powell K, Clayton L et all The natural history of human papillomavirus in fection as measmed by repeated DNA Testing in adolescent and young women. J. Pediatr 1998 Feb. ,132(2) 277-284
15.- Muller CY,,O,Boile Jd, Fong Km, Wstuba II, Biesterveld E, Ahmadian M, Miller DS et all. Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type. J Natl Cancer Inst 1998 Mar 18,90 )6):433-439
|
|
